13F HOLDINGS REPORT
RiverVest Venture Management LLC
Quarter ended Q1 2023 · Filed February 14, 2023 · Accession 0001104659-23-019931
Total Value
$85.7M
Positions
6
Other Managers
0
Confidential Omitted
No
Holdings (6)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | Allakos, Inc. | 01671P100 | 4,887,932 | $41.2M | 48.01% |
| 2 | Mirum Pharmaceuticals, Inc. | MIRM | 1,621,118 | $31.6M | 36.87% |
| 3 | Reneo Pharmaceuticals, Inc. | 75974E103 | 2,409,220 | $5.6M | 6.55% |
| 4 | Xilio Therapeutics, Inc. | XLO | 1,441,444 | $3.9M | 4.52% |
| 5 | Spruce Bioscience, Inc. | SPRB | 2,148,281 | $2.4M | 2.75% |
| 6 | Vapotherm, Inc. | 922107107 | 412,558 | $1.1M | 1.30% |